Pro Medicus Ltd (ASX: PME) shares are having another strong session on Thursday as investors continue to buy back into the ASX healthcare stock.

At the time of writing, the Pro Medicus share price is up 2.05% to $182.66.

It has been a big month for the company’s shares, which have now climbed around 40% over that period.

That bounce has helped repair some of the damage from earlier in the year. Even after the recent rally, Pro Medicus shares are still down roughly 17% since the start of 2026.

The latest announcement appears to have given the rally another push.

Pro Medicus signs AI agreement

According to the release, Pro Medicus has signed binding heads of agreement (HoA) with Echo IQ Ltd (ASX: EIQ).

The deal would see Pro Medicus take a stake in Echo IQ and work with the company to sell its products in the US.

Echo IQ is an AI and medical technology company working in cardiology. Its software is designed to help doctors make decisions using heart imaging data.

Under the agreement, Pro Medicus will make an initial $10 million investment in Echo IQ through secured convertible notes.

There is also room for another $10 million investment if Echo IQ receives US Food and Drug Administration clearance for its EchoSolv HF product.

EchoSolv HF is an AI-powered tool that helps identify heart failure risk using cardiac imaging data.

Furthermore, the agreement includes a proposed reseller arrangement. This allows Pro Medicus to market and distribute Echo IQ’s products to its healthcare customers, particularly in the United States.

Echo IQ deal opens another door

The update seems to have gone down well because it gives Pro Medicus another way to build out its cardiology offering.

The company is already best known for its Visage Imaging platform, which is used by large healthcare groups to view and manage medical images.

This agreement could add Echo IQ’s AI technology to the mix, while giving Echo IQ access to a much larger customer network.

Pro Medicus CEO Dr Sam Hupert said the company is “looking to offer Visage 7 Cardiology customers the option of using Echo IQ’s technology.”

He said the agreement fits with the company’s strategy of offering a carefully selected suite of algorithms. That includes its own technology, tools created with clinical partners, and third-party algorithms such as Echo IQ.

What comes next?

It’s worth remembering that despite the positive news, the agreement still needs final legal documentation.

The companies said the deal is expected to be finalised in the coming weeks.

Echo IQ also said its FDA submission for EchoSolv HF remains on track for an outcome in the near-term.

The post Pro Medicus shares jump again as AI deal adds fuel to 40% rally appeared first on The Motley Fool Australia.

More reading

• Pro Medicus signs Echo IQ deal to boost AI cardiology offering
• 2 ASX 200 shares I’d buy for powerful growth
• 3 buy-rated ASX tech shares with bright futures
• US chip stocks were smashed overnight. So why are ASX tech shares rising?
• 5 ASX growth shares I want in my portfolio in FY27

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Lendlease Group (ASX: LLC) share price is in focus today after a trading pause was announced by the ASX, pending further updates from the company.

What did Lendlease Group report?

• Trading in Lendlease securities has been temporarily paused by the ASX.
• No financial metrics or earnings details have been disclosed at this time.
• Investors await a further announcement regarding the reason for the trading halt.

What else do investors need to know?

The ASX has temporarily paused trading of Lendlease Group shares as it awaits additional information from the company. This is a standard procedure when the market is expecting material news that could affect the share price.

It’s not uncommon for companies to request a trading halt ahead of significant announcements, which might range from financial results, capital raisings, acquisitions, or other strategic updates. Lendlease has not provided specific details yet.

What’s next for Lendlease Group?

All eyes are on Lendlease for its next announcement, which should clarify the reason for the trading pause. Investors will be looking for more information before making any decisions.

The company’s future direction will become clearer once further details are released to the market.

Lendlease Group share price snapshot

Over the past 12 months, Lendlease shares have declined 47%, trailing the S&P/ASX 200 Index (ASX: XJO), which has risen 3% over the same period.

View Original Announcement

The post Lendlease Group shares paused pending further announcement appeared first on The Motley Fool Australia.

More reading

• Corporate Travel Management updates investors on delayed FY25 results and UK remediation
• Worley flags FY26 earnings hit from Middle East delays and currency impact
• Pro Medicus signs Echo IQ deal to boost AI cardiology offering
• Ventia Services appoints new CEO in leadership succession
• A2 Milk declares $300 million special dividend after securing China approval

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

The Corporate Travel Management Ltd (ASX: CTD) share price is in focus after the company released an update highlighting delays to its FY25 and 1HFY26 financial statements and progress on UK customer remediation.

What did Corporate Travel Management report?

• FY25 and 1HFY26 financial statements are substantially advanced but still incomplete
• FY25 and 1HFY26 accounts now expected to be lodged in August 2026
• Estimated FY24 revenue restatement of $10–15 million in the ANZ region, mostly relating to prior years
• Impairment of Europe goodwill expected at GBP 92 million
• Further goodwill impairment expected in ANZ (AUD 77 million) and North America (USD 49 million)

What else do investors need to know?

Corporate Travel Management is focused on completing three key, interconnected activities: finalising financing to support UK remediation, executing agreements with affected UK customers, and completing outstanding financial reporting and audit procedures.

The UK remediation process is well advanced, with Corporate Travel Management in the final stages of negotiating staged refund arrangements with key customers. This remains subject to completion of the FY25 accounts and associated financing, with lenders engaged regarding these developments.

What did Corporate Travel Management management say?

Acting Group CEO Ana Pedersen said:

We recognise the delay is deeply frustrating for shareholders and acknowledge the uncertainty it has created.

We have made meaningful progress towards finalising CTM’s financial statements, UK customer remediation and financing workstreams.
As we move through the final stages, the remaining tasks are interdependent, and we are working through them carefully and with rigour, to ensure a thorough and appropriate outcome.

Importantly, the underlying business remains resilient, with strong customer retention and consistent quality service across our global operations.

What’s next for Corporate Travel Management?

The company now aims to complete and lodge its FY25 and 1HFY26 financial statements in August. Finalising agreements with lenders and impacted UK customers remains a top priority, alongside implementing the staged remediation refunds.

Management says the underlying operations continue to display resilience, and the company will provide further market updates as soon as the remaining processes are finalised.

View Original Announcement

The post Corporate Travel Management updates investors on delayed FY25 results and UK remediation appeared first on The Motley Fool Australia.

More reading

• Lendlease Group shares paused pending further announcement
• Worley flags FY26 earnings hit from Middle East delays and currency impact
• Pro Medicus signs Echo IQ deal to boost AI cardiology offering
• Ventia Services appoints new CEO in leadership succession
• A2 Milk declares $300 million special dividend after securing China approval

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Corporate Travel Management. The Motley Fool Australia has positions in and has recommended Corporate Travel Management. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.